How should healthcare companies manage AI-generated health information that mentions them?

Healthcare AI reputation work carries unusually high stakes: the answers engines give about medical and pharmaceutical topics can influence patient decisions, clinician behavior, and regulatory posture, so an inaccurate AI claim is not only a reputational problem but a potential safety and compliance one. Managing it well means tighter monitoring than most categories and remediation anchored in authoritative medical sources.

Documented risk: AI engines are unreliable on clinical topics

This is not a theoretical concern. A 2025 cross-sectional study published in Frontiers in Digital Health tested ChatGPT-3.5, ChatGPT-4o, Copilot, Gemini, Claude, and Perplexity against clinical practice guidelines for lumbosacral radicular pain and found that consistency of responses ranged from “unacceptable” (median 26%) to “questionable” (median 68%) across all engines. No engine performed at a level that would be acceptable for clinical guidance. When AI engines are this unreliable on a studied clinical topic, the same variability applies to the engines’ answers about a healthcare brand’s products, indications, and safety profile, claims that can reach patients and clinicians at scale.

Why the stakes are higher in healthcare

AI engines synthesize answers from across a brand’s digital footprint and can state false or inappropriate claims with confident fluency, fabricated details delivered in the same authoritative tone as accurate ones. When the subject is a medical product or condition, that failure mode does real-world damage. The claims that matter most include:

• Misstated indications, a product described as treating something it is not approved or intended for.
• Wrong contraindications, safety guidance that is inaccurate or reversed.
• Fabricated trial results, efficacy or outcome claims that match no real study.
• Inaccurate adverse-event characterizations, over- or understated safety signals.

Because these errors can affect patient and clinician decisions, the consequences extend beyond the reputational layer into patient-safety and compliance exposure.

Tighter monitoring discipline

The monitoring cadence is correspondingly stricter: frequent AIQ polling across the engines AIQ tracks, with prompts covering products, conditions, comparisons, and safety topics so emerging inaccuracies are caught early rather than after they propagate. Each of the major engines: ChatGPT, Gemini, Copilot, Perplexity, Claude, Grok, Google AI Overviews, and Google AI Mode, can return different answers to the same clinical query, making cross-engine coverage essential rather than optional.

Remediation grounded in authoritative sources

Corrective work should be backed by the highest-authority medical references available, peer-reviewed literature, official drug labeling, government health resources, major medical reference sites, and professional society guidelines. Google, OpenAI, and Anthropic each offer a formal feedback channel for reporting incorrect AI-generated information, which can be one part of a remediation strategy alongside improving the underlying source ecosystem the engines draw from. The work is unglamorous, but in healthcare the cost of neglecting it is substantial.